Applying ASCO GU 2024 Data to Clinical Practice in Bladder, RCC Care
Paul V. Viscuse, MD, spotlights key data from the 2024 Genitourinary Cancers Symposium in bladder cancer and renal cell carcinoma.
Source: onclive.com
📰 Practice Guidelines News
Page 3 - Practice Guidelines News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.
Connie Barden Receives AACN Award for Distinguished Career
Connie Barden, retired chief clinical officer of the American Association of Critical-Care Nurses, to be honored for her tremendous impact on nursing practice,
United States Marguerite Rodgers Kinney Connie Barden American Academy Of Nursing University Of North Carolina At Chapel Hill National Teaching Institute Critical Care Exposition
Source: newswise.com
Connie Barden Receives AACN Award for Distinguished Career
Connie Barden, retired chief clinical officer of the American Association of Critical-Care Nurses, to be honored for her tremendous impact on nursing practice,
United States Marguerite Rodgers Kinney Connie Barden University Of North Carolina At Chapel Hill American Academy Of Nursing Institute In Miami
Source: newswise.com
Flying Nickel Announces 405,020 oz of M&I Inaugural Platinum and Palladium Mineral Resource; 41.95% Increase of In-Pit M&I Nickel Resource at the Minago Nickel PGM Project
Flying Nickel Mining Corp. announces the results of an updated Mineral Resource Estimate prepared in accordance with the CIM Definition Standards for Mineral Resources and Mineral Reserves and CIM MRMR Best Practice Guidelines for its 100% owned... - Veroeffentlicht am 11.04.2024
Source: goldseiten.de
Breaking Nickel Stock News: Flying Nickel (TSXV: FLYN) Announces 405,020 oz of M&I Inaugural Platinum and Palladium Mineral Resource; 41.95% Increase of In-Pit M&I Nickel Resource at the Minago Nickel PGM Project
Breaking Nickel Stock News: Flying Nickel (TSXV: FLYN) Announces 405,020 oz of M&I Inaugural Platinum and Palladium Mineral Resource; 41.95% Increase of In-Pit M&I Nickel Resource at the Minago Nickel PGM Project
Source: investorideas.com
When Does the PD-1 Inhibitor Come Before the Hedgehog Inhibitor for Neoadjuvant BCC/CSCC?
Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers.
United States University Of California San Francisco Vishala Patel Rebeccai Hartman Anne Lynns Chang Michaelr Migden
Source: onclive.com
NCCN and Flatiron Health Announce Collaboration to Improve Cancer Care Quality with Real-World Data
NEW YORK--(BUSINESS WIRE)--Apr 10, 2024--
Source: eagletribune.com
AstraZeneca Plc's Enhertu approved in the US for HER2+ solid tumours
AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment.
United States Ken Keller Dave Fredrickson Daiichi Sankyo University Of Texas Md Anderson Cancer Center Daiichi Sankyo Inc
Source: directorstalkinterviews.com
Daiichi Sankyo : ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors (375.5KB -April 05, 2024 at 11:34 pm EDT
Press Release ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2...
United States Ken Keller Daiichi Sankyo Dave Fredrickson University Of Texas Md Anderson Cancer Center American Society Of Clinical Oncology
Source: marketscreener.com
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Apr 5, 2024--
United States Daiichi Sankyo Jennifer Brennan Dave Fredrickson Ken Keller American Society Of Clinical Oncology
Source: valdostadailytimes.com